Suppr超能文献

microRNA-30d 通过靶向调控 Galphai2 促进肝癌的侵袭和转移。

MicroRNA-30d promotes tumor invasion and metastasis by targeting Galphai2 in hepatocellular carcinoma.

机构信息

Shanghai Medical College, Fudan University, Shanghai, China.

出版信息

Hepatology. 2010 Mar;51(3):846-56. doi: 10.1002/hep.23443.

Abstract

UNLABELLED

The pathological relevance and significance of microRNAs (miRNAs) in hepatocarcinogenesis have attracted much attention in recent years; however, little is known about the underlying molecular mechanisms through which miRNAs are involved in the development and progression of hepatocellular carcinoma (HCC). In this study, we demonstrate that miR-30d is frequently up-regulated in HCC and that its expression is highly associated with the intrahepatic metastasis of HCC. Furthermore, the enhanced expression of miR-30d could promote HCC cell migration and invasion in vitro and intrahepatic and distal pulmonary metastasis in vivo, while silencing its expression resulted in a reduced migration and invasion. Galphai2 (GNAI2) was identified as the direct and functional target of miR-30d with integrated bioinformatics analysis and messenger RNA array assay. This regulation was further confirmed by luciferase reporter assays. In addition, our results, for the first time, showed that GNAI2 was frequently suppressed in HCC by way of quantitative reverse-transcription polymerase chain reaction and immunohistochemical staining assays. The increase of the GNAI2 expression significantly inhibits, whereas knockdown of the GNAI2 expression remarkably enhances HCC cell migration and invasion, indicating that GNAI2 functions as a metastasis suppressor in HCC. The restoration of GNAI2 can inhibit miR-30d-induced HCC cell invasion and metastasis.

CONCLUSION

The newly identified miR-30d/GNAI2 axis elucidates the molecular mechanism of HCC cell invasion and metastasis and represents a new potential therapeutic target for HCC treatment.

摘要

未标记

近年来,微小 RNA(miRNAs)在肝癌发生中的病理相关性和意义引起了广泛关注;然而,miRNAs 如何参与肝细胞癌(HCC)的发展和进展的潜在分子机制知之甚少。在这项研究中,我们证明 miR-30d 在 HCC 中经常上调,其表达与 HCC 的肝内转移高度相关。此外,miR-30d 的增强表达可促进 HCC 细胞在体外的迁移和侵袭以及体内的肝内和远端肺转移,而沉默其表达则导致迁移和侵袭减少。Galphai2(GNAI2)被鉴定为 miR-30d 的直接和功能靶标,通过整合的生物信息学分析和信使 RNA 阵列分析。荧光素酶报告基因检测进一步证实了这种调控。此外,我们的结果首次表明,GNAI2 通过定量逆转录聚合酶链反应和免疫组织化学染色检测在 HCC 中经常受到抑制。GNAI2 表达的增加显著抑制,而 GNAI2 表达的敲低则显著增强 HCC 细胞的迁移和侵袭,表明 GNAI2 在 HCC 中作为转移抑制因子发挥作用。GNAI2 的恢复可以抑制 miR-30d 诱导的 HCC 细胞侵袭和转移。

结论

新鉴定的 miR-30d/GNAI2 轴阐明了 HCC 细胞侵袭和转移的分子机制,代表了 HCC 治疗的新潜在治疗靶点。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验